Phylonix Pharmaceuticals, Inc. today announced that it has been awarded a $1,092,031 Phase II Small Business Innovation Grant (SBIR) from the National Eye Institute of the National Institutes of Health (NIH) to develop zebrafish eye disease models for drug screening. The grant for “New Models for Eye Diseases” will support the Phylonix program over a period of three years.
Prof. Ehud Assia, of Tel Aviv University?s Sackler School of Medicine is, quite simply, a rock star in the field of eye surgery. One of a small number of surgeons in the world who currently perform a complicated form of glaucoma surgery, Prof. Assia has developed a novel laser device that promises to revolutionize treatment of the disease.
Fluctuations in eye pressure may be associated with a decreasing peripheral field of vision in patients with glaucoma, even if their eye pressure remains low overall, according to a report in the August issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Purdue University researchers have developed new miniature devices designed to be implanted in the brain to predict and prevent epileptic seizures and a nanotech sensor for implantation in the eye to treat glaucoma.
deCODE scientists have identified a sequence variant responsible for virtually all cases of a major subtype of glaucoma. The protein encoded by the gene appears to have a clear pathophysiologal role.
UK scientists have shown for the first time that key proteins involved in Alzheimer’s disease are also implicated in glaucoma, the major cause of irreversible blindness worldwide. Research carried out at the UCL Institute of Ophthalmology and funded by the Wellcome Trust has also shown that novel drugs being trialled for Alzheimer’s disease which target this protein may be used to treat glaucoma.
Iowa State University researchers have developed a new technique that successfully treated rats for blindness caused by glaucoma. Their experimental treatment will be used on canine patients in the next year. If successful, it is expected to move to human trials.
A special type of cell found in the eye has been found to be very important in regenerating the retina in zebrafish and restoring vision even after extensive damage.
A unique nanoparticle made in a laboratory at the University of Central Florida is proving promising as a drug delivery device for treating glaucoma, an eye disease that can cause blindness and affects millions of people worldwide.
Individuals with a high pulse pressure (the difference between the systolic [top number] and diastolic [bottom number] blood pressure), appear to have an increased risk for high-tension open-angle glaucoma, according to a report in the June issue of Archives of Ophthalmology, one of the JAMA/Archives journals.